“22q Deletion Syndrome - Why we should be screening in the UK. “ WEBINAR Tuesday 15th December.
Hosted by Natera

WEBINAR Tuesday 15th December.
Click on the link to register!
https://register.gotowebinar.com/rt/3514062663334734091?fbclid=IwAR1fG1Amppyur_1Dd1o8-O7Va0Lf7-B4wZjP3PzR5nT1uSZsMV-p3hgHC6c

Agenda:
1. Patient and Family Perspective -- Speaker: Martin Kennedy, Max Appeal
2. Why Should We be Screening in the UK -- Speaker: Dr. Bryan Beattie, MD FRCOG, Consultant in Obstetrics and Fetal Medicine
3. Genetics and Test Performance -- Speaker: Dr. Samantha Leonard, MBBS BSc (Hons) MA PhD MRCPCH, Senior Medical Director International at Natera, Inc.
4. Q&A
In our 40 minutes webinar, followed by a Q&A session, you will learn about:
• The impact of 22q11.2 deletion diagnosis on parents and families and how the Max Appeal Charity Organization can support.
• How to supportively counsel your patients regarding prenatal screening and diagnosis, key facts and clinical implications of 22q11.2 deletion syndrome.
• Genetics of 22q11.2 deletion syndrome, clinical experience and prenatal screening.
register.gotowebinar.com
1. Patient and Family Perspective -- Speaker: Martin Kennedy, Max Appeal
2. Why Should We be Screening in the UK -- Speaker: Dr. Bryan Beattie, MD FRCOG, Consultant in Obstetrics and Fetal Medicine
3. Genetics and Test Performance -- Speaker: Dr. Samantha Leonard, MBBS BSc (Hons) MA PhD MRCPCH, Senior Medical Director International at Natera, Inc.
4. Q&A
In our 40 minutes webinar, followed by a Q&A session, you will learn about:
• The impact of 22q11.2 deletion diagnosis on parents and families and how the Max Appeal Charity Organization can support.
• How to supportively counsel your patients regarding prenatal screening and diagnosis, key facts and clinical implications of 22q11.2 deletion syndrome.
• Genetics of 22q11.2 deletion syndrome, clinical experience and prenatal screening.
register.gotowebinar.com